恩威医药：恩威集团质押500万公司股份

Core Viewpoint - Enwei Pharmaceutical announced that its controlling shareholder, Enwei Group, has pledged 5 million shares of the company, representing 16.82% of its holdings and 4.86% of the total share capital of the company [1] Summary by Relevant Sections - Pledge Details - The pledge started on November 17, 2025, and the purpose is for the group's own production and operation [1] - After this pledge, the total pledged shares by Enwei Group account for 93.77% of its holdings and 27.10% of the company's total share capital [1]